PAVmed Inc. Cost of Revenue
PAVmed Inc. (PAVM) reported Cost of Revenue of $122.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-13
- PAVmed Inc. cost of revenue for the quarter ending 2026-06-30 was $122.00K, a 197.56% increase year-over-year.
- PAVmed Inc. cost of revenue for the quarter ending 2026-03-31 was $97.00K, a 169.44% increase year-over-year.
- PAVmed Inc. cost of revenue for the quarter ending 2025-12-31 was $85.00K, a 77.08% increase year-over-year.
- PAVmed Inc. cost of revenue for the quarter ending 2025-09-30 was $55.00K, a 96.02% decline year-over-year.
- PAVmed Inc. cost of revenue for fiscal 2025 was $218.00K, a 95.50% decline from fiscal 2024.
- PAVmed Inc. cost of revenue for fiscal 2024 was $4.84M, a 24.61% decline from fiscal 2023.
- PAVmed Inc. cost of revenue for fiscal 2023 was $6.42M, a 77.64% increase from fiscal 2022.
- PAVmed Inc. cost of revenue for fiscal 2022 was $3.61M, a 517.78% increase from fiscal 2021.
| Period end | Cost of Revenue | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $122.00K 10-Q · filed 2026-08-13 | $219.00K 10-Q · filed 2026-08-13 | $304.00K derived: sum of 3 quarters · filed 2026-08-13 | $359.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $97.00K 10-Q · filed 2026-05-14 | $182.00K derived: sum of 2 quarters · filed 2026-05-14 | $237.00K derived: sum of 3 quarters · filed 2026-05-14 | $278.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $140.00K derived: sum of 2 quarters · filed 2026-03-27 | $181.00K derived: sum of 3 quarters · filed 2026-08-13 | $218.00K 10-K · filed 2026-03-27 | |
| 2025-09-30 | $55.00K 10-Q · filed 2025-11-12 | $96.00K derived: sum of 2 quarters · filed 2026-08-13 | $133.00K 10-Q · filed 2025-11-12 | $180.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $41.00K 10-Q · filed 2026-08-13 | $78.00K 10-Q · filed 2026-08-13 | $125.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.51M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $36.00K 10-Q · filed 2026-05-14 | $84.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.47M derived: sum of 3 quarters · filed 2026-05-14 | $3.13M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $1.43M derived: sum of 2 quarters · filed 2026-03-27 | $3.10M derived: sum of 3 quarters · filed 2026-03-27 | $4.84M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $1.38M 10-Q · filed 2025-11-12 | $3.05M derived: sum of 2 quarters · filed 2025-11-12 | $4.79M 10-Q · filed 2025-11-12 | $6.40M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-09-10 | $36.00K 10-Q · filed 2025-05-15 | ||||
| 2024-06-30 | $1.67M 10-Q · filed 2025-08-14 | $3.41M 10-Q · filed 2025-08-14 | $5.02M derived: sum of 3 quarters · filed 2025-08-14 | $6.80M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $1.74M 10-Q · filed 2025-05-15 | $3.35M derived: sum of 2 quarters · filed 2025-05-15 | $5.13M derived: sum of 3 quarters · filed 2025-05-15 | $6.82M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $3.39M derived: sum of 2 quarters · filed 2025-03-24 | $5.08M derived: sum of 3 quarters · filed 2025-03-24 | $6.42M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $1.78M 10-Q · filed 2024-11-14 | $3.46M derived: sum of 2 quarters · filed 2024-11-14 | $4.81M 10-Q · filed 2024-11-14 | $6.43M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $1.69M 10-Q · filed 2024-08-12 | $3.03M 10-Q · filed 2024-08-12 | $4.65M derived: sum of 3 quarters · filed 2024-08-12 | $6.28M derived: sum of 4 quarters · filed 2024-08-12 | |
| 2023-03-31 | $1.35M 10-Q · filed 2024-05-13 | $2.96M derived: sum of 2 quarters · filed 2024-05-13 | $4.59M derived: sum of 3 quarters · filed 2024-05-13 | $4.59M derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $3.24M derived: sum of 2 quarters · filed 2024-03-25 | $3.24M derived: sum of 3 quarters · filed 2024-03-25 | $3.61M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $1.63M 10-Q · filed 2023-11-13 | $1.63M derived: sum of 2 quarters · filed 2023-11-13 | $2.00M 10-Q · filed 2023-11-13 | $2.44M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | $369.00K 10-Q · filed 2023-08-14 | $810.00K derived: sum of 3 quarters · filed 2023-08-14 | $954.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $369.00K 10-Q · filed 2023-05-15 | $810.00K derived: sum of 2 quarters · filed 2023-05-15 | $954.00K derived: sum of 3 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $441.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $585.00K derived: sum of 2 quarters · filed 2023-03-14 | $585.00K 10-K · filed 2023-03-14 | ||
| 2021-09-30 | $144.00K 10-Q · filed 2022-11-14 | $144.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InspireMD, Inc. (NSPR) | $0.033B | ||
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |